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Abstract
Objective: The 2019 coronavirus disease (COVID-19) is a global pandemic with no therapy,
and pharmacists being a part of the health care system have a vital role in the management of
COVID-19. The purpose of this study is to assess the knowledge, attitude, and practices of com-
munity pharmacists (CPs) regarding COVID-19.
Method: An online survey was conducted among 393 CPs in 2 provinces of Pakistan during
the lockdown period. A validated questionnaire (Cronbach’s alpha, 0.745) was used for data
collection. All statistical analyses were analyzed by using SPSS, version 21 (IBM Corp,
Armonk, NY).
Results: Among 393 participants, 71.5% (n= 281) had good knowledge, 44% (n= 175) had a
positive attitude, and 57.3% (n= 225) had good practices regarding COVID-19. Social media
(45.29%, n= 178) were reported as the main source to seek information of COVID-19. Good
knowledge, age≥ 26 years, and a PhD degree level were the substantial determinants
(P=< 0.05) of a good attitude. Similarly, a CP with experience of> 5 years, a PhD degree, good
knowledge, and a good attitude has higher odds of having good practices as compared with
reference categories (P=< 0.05).
Conclusion: In short, a majority of the CPs had good knowledge but had a poor attitude and
practice toward the management of COVID-19. Standard-structured educational and counsel-
ing programs for CPs regarding COVID-19 are needed for effective management.
Introduction
The 2019 coronavirus disease (COVID-19), caused by severe acute respiratory syndrome coro-
navirus 2 (SARS-CoV-2), emerged from Wuhan, China, in December 2019 and created a
remarkable panic in China and globally. Cases of COVID-19 were no longer limited to
China, with the increasing number of cases and widening geographical spread raising grave con-
cerns about the future trajectory of the outbreak.1 Coronavirus is a zoonotic beta-coronavirus
similar to the viruses responsible for causing SARS in China and the Middle East respiratory
syndrome (MERS) in Saudi Arabia. SARS-CoV-2 is spread through close contact with persons,
coughing, and sneezing. Major symptoms are fever, dry cough, shortness of breath, and may
sometimes include severe diseases, such as pneumonia, respiratory distress, and death.2,3 The
World Health Organization (WHO) declared the COVID-19 outbreak a public health emer-
gency and a global pandemic on March 11, 2020.1 According to the WHO situation report –
180 on COVID-19, by July 18, 2020, there were 138 76 441 confirmed cases and 593 087 deaths
reported globally.4
Experience gained from the previous SARS outbreak in 2002 suggests that knowledge and
attitude toward contagious infections are linked with a level of panic affection amid the com-
munity, which can further complicate chances to inhibit the transmission of the infection.5
Therefore, it is imperative that the community be equipped with empirically precise knowledge
and tools to address and cope with the impact of COVID-19 effectively. Currently, COVID-19 is
a public health emergency and needs cooperation by individuals to halt further transmission by
following given guidelines, government orders, and a range of pre-
ventive measures.6 The health care system of different countries
started effective planning to cope with the COVID-19 pandemic.
Pharmacists are an important part of the health care system, and
their role is critical in completing the management cycle of the new
coronavirus outbreak.3,7 Pharmacists being a member of the health
care team can play an important role in disease management and
outbreak surveillance.8 Globally, in the current situation of lock-
down, pharmacies are among the few shops or places that are kept
open for public services, and therefore community pharmacists
(CPs) are the first point of contact to the community to help fulfill
their health care needs.9
The International Pharmaceutical Federation (FIP) emphasized
the effective role of pharmacists in the community for preventing
the spread of COVID-19.10 The CPs often act as a reliable infor-
mation source for individuals having concerns or needing infor-
mation and advice regarding ailments. Moreover, pharmacists
are readily available at community pharmacies and accessible to
the general population.9 The CPs across the world have a central
role to play an effective role in COVID-19 preventive measures and
action.
A study from China acknowledged that community pharmacy
management teams shall support different services by providing an
adequate supply of COVID-19-related medications and preventive
products, in addition to providing sufficient staff training.11 From
Colombia, CPs were proposed to contribute to the early detection
and appropriate referral of possible cases of the virus, then to be
reported through designated telephone lines, in addition to provid-
ing patient education.12 Health care teams include pharmacists
who are responsible for providing knowledge, delivering good
quality management, and protecting individuals from an illness
during the pandemic period. Therefore, pharmacy students’
education should include training in precautionary measures,
effective treatment, and follow-up. This is critical, together with
their behavior in these fields. Normally, training in disaster medi-
cine occupies a very small place in regular medical curricula
globally.13
Soon, the confirmed and fatality cases of COVID-19 are
expected to increase significantly in limited resources due to the
weak health care system and facilities.14 Pakistan is a low-middle
income and limited resource country with themost vulnerable geo-
graphical surroundings as it shares borders with the most affected
countries, such as China, India, and Iran. According to the WHO,
COVID-19 situation report 180: 261 917 cases and 5522 deaths
were reported in Pakistan.4 The Pakistani health care system
faces a lack of basic health facilities, recommended policies,
unavailability of proper medical equipment, financial crisis,
and a limited number of health care professionals (HCPs) to
handle such an outbreak.15 There is limited availability of the
CPs in Pakistan, and also their role is not properly defined.16
The fight against COVID-19 is continuing in Pakistan, and
the involvement of CPs and their role is needed to effectively
manage the fight against this global threat.
The knowledge, attitude, and practices (KAPs) survey provides
a design to evaluate existing programs and to identify effective
strategies for behavior change in society. Currently, there is limited
information regarding the awareness level of CPs in Pakistan. The
KAPs survey offers a convenient plan to check the existing pro-
grams and to find out adequate approaches for behavior change
in the community. To promote COVID-19 outbreak management
in Pakistan, it is very important to find out the awareness of CPs
about COVID-19 in the current serious situation. In the present
research, we determined the KAP of CPs toward COVID-19
during the fast rise period of the pandemic.
Methodology
Study Design
An online cross-sectional survey was conducted from April 10–30,
2020, during the lockdown period. During this time, it was difficult
to conduct a community-based sampling survey; therefore, we pre-
ferred using a convenient sampling model for data collection from
2 provinces (Punjab and Khyber Pakhtunkhwa) of Pakistan. Total
registered pharmacists in Pakistan are 34 000. From this number,
26 000 of them are registered in Punjab and 3000 in Khyber
Pakhtunkhwa.17 Lahore and Peshawar are the metropolitan cities
of Punjab and Khyber Pakhtunkhwa, respectively, and represent
the remaining cities. CPs were sought through different pharmacist
groups, academic institutions, colleague pharmacists, and other
sources, and the questionnaire was shared with them. This study
was carried out among CPs who are educated and trustworthy
and responded to the questionnaire with honesty and profession-
alism. In both cities, a prodigious number of pharmacies are
present where CPs serve the health care profession and patients.
A study reported that only 10% (n= 2900) of registered pharma-
cists are working at community pharmacies in Pakistan.16
Sample Size
The minimum obligatory sample size calculated was 340 by using
Raosoft software,18 with a population size of 2900. Response dis-
tribution was assumed as 50%, power was kept at 80%, the margin
of error 5%, and a 95% confidence level was chosen for sample esti-
mation. Taking into consideration an additional 20% (n= 68) for
nonresponse, inappropriate responses, and error in questionnaire
filling, a final sample size of 408 pharmacists will be required.
Data Collection
The survey was started on April 10, 2020, and response acceptance
was closed on April 30, 2020, when the required sample size was
achieved. An online questionnaire was sent to the CPs via various
social media sources (WhatsApp, Facebook, Gmail, and LinkedIn).
Pharmacists working in hospitals, the pharmaceutical industry,
and marketing industries were excluded from this study.
Data Collection Tool
A questionnaire was developed according to the COVID-19 guide-
lines of the FIP for pharmacists and the pharmacy workforce,10 and
the national action plan for COVID-19 in Pakistan.19 A pilot study
was conducted on 40 pharmacists, 20 from each province. The reli-
ability coefficient was estimated by using SPSS, version 21 (IBM
Corp, Armonk, NY), and Cronbach’s alpha was 0.745.
There were 5 sections of the questionnaire: demographics, basic
questions, and KAPs. Demographic variables included age, gender,
work areas, marital status, pharmacy ownership, CP experience,
and qualifications. Basic questions contained the source of knowl-
edge, need for more education and training, and the level of con-
cern about COVID-19. The third part of the questionnaire was
related to knowledge, and this section had 24 questions where 1
point was assigned to the correct answer and 0 points were
assigned to the wrong answer. A score of ≤ 19 indicted poor knowl-
edge and a score of ≥ 20 demonstrated good knowledge. The fourth
section was on attitude and had 13 questions on a 5-point Likert
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scale as strongly disagree = 1, disagree = 2, uncertain = 3,
agree= 4, and strongly agree= 5. A score of ≤ 52 indicated a poor
attitude and a score of ≥ 53 demonstrated a good attitude. The last
part of the questionnaire was composed of 8 questions related to
the practice, and each question was scored as “yes” (1-point), “no”
(0-point), and “sometimes” (0-point). A score of ≤ 6 demonstrated
poor practice, whereas a score of 7–8 indicated good practice.
Ethical Approval
The study was carried out according to the Declaration of Helsinki
and conducted in a strict lockdown period when educational insti-
tutes were also closed; hence, the study protocol was approved by
the ethical committee of the teaching hospital (Reference number:
817/THQ/HR).
Statistical Analysis
A statistical analysis was performed using SPSS version 21 (IBM
Corp, Armonk, NY). Descriptive statistics were measured as
frequencies and percentages for categorical variables. Chi-square
tests were used to check a difference in KAP by participants’ char-
acteristics. Multivariable binary logistic regression models were
employed to find potential factors linked with good KAP.
Results were stated as odds ratios accompanied by a 95% confi-
dence interval. Pearson correlation tests were applied to determine
the nature of correlation among KAP sections. A P-value of less
than 0.05 was considered as a level of significance.
Results
Participants totaling 393 (15 responses were excluded due to errors
in completing questionnaires) were included in the final analysis,
of which half (52.2%, n= 205) of the respondents were male, 71%
(n= 279) were single, and a similar proportion (72.3%, n= 284)
was working as an employee in a pharmacy. The majority of the
CPs (67.4%, n= 265) had related work experience of 5 years or less,
69% (n= 271) of the participants had a PharmD degree, and 85.8%
(n= 337) wished to obtain more education and training regarding
COVID-19 (Table 1).
The majority of the respondents used social media (45.29%, n
= 178) as the main source to seek information regarding COVID-
19 followed by research articles (18.57%, n= 73) and the ministry
of health website (14.5%, n= 57) (Figure 1).
Knowledge Among CPs Regarding COVID-19
Overall, the majority of respondents (71.5%, n= 281) had good
knowledge regarding COVID-19. More than 90% of the partici-
pants had good knowledge regarding the nature, symptoms, risky
groups, and transmission of COVID-19. Additionally, 81.6% of
participants were aware that there is no vaccine available in the
market, and 98.2% reported that gathering in crowds is one of
the major factors in the spread of disease. Only 30.8% didn’t know
that it is a zoonotic disease, and 28.8% reported that antibiotics are
the first-line treatment (Supplementary File 1).
Attitude Among CPs Regarding COVID-19
Attitude-related findings demonstrated that only 44% (n= 173) of
the CPs had a positive attitude toward COVID-19. Moreover,
65.4% strongly agreed that COVID-19 is a world health concern,
less than half (47.6%) agreed that it is also a problem in Pakistan,
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High concern 122 31.0
Moderate concern 35 8.9
Low concern 3 0.8
Very low concern 1 0.3
Figure 1. The various information sources used by community pharmacists
(n= 393).
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50.6% strongly agreed that pharmacists should avail themselves
of updated knowledge, and more than 92% of the respondents
strongly agreed that CPs can play an important role in this
pandemic. Only 36.1% of the CPs disagreed that the Pakistani
populations have sufficient information, and 20.4% disagreed
that government institutions can control the pandemic
(Supplementary File 2).
Practice Among CPs Regarding COVID-19
More than half (57.3%, n= 225) of the CPs had followed good
practices regarding COVID-19. The majority had good practice
regarding each item with the highest practice showed in putting
used tissue in the basket (91.9%), wearing a face mask (91.6%),
washing hands (90.6%), and covering the eyes and nose with tissue
(90.3%). A lower percentage of good practice was observed among
CPs in wearing protective gowns (57.5%) and in avoiding touching
of eyes, nose, or mouth (74.6%) (Figure 2).
Difference in KAPs Score Among CPs About COVID-19
Chi-square tests were used to assess a difference in KAP by sample
characteristics. CP knowledge regarding COVID-19 was signifi-
cantly different by gender (χ2= 18.78, P=< 0.001) and level of
concern (χ2= 11.603, P= 0.021). The respondents who had a very
high concern regarding the COVID-19 pandemic in Pakistan also
had good knowledge as compared with those pharmacists who had
less concern. Results showed that more than half (56%, n= 220) of
the CPs had a poor attitude regarding COVID-19. Factors that
differentiated attitude status were gender (χ2= 4.789, P= 0.033),
education level (χ2 = 6.093, P= 0.047), and level of concern
(χ2 = 12.886, P= 0.005).
Of the 393 CPs, only 57.3% had good practice in following pre-
cautionary measures regarding COVID-19. Findings demon-
strated that female pharmacists had good practice in following
precautions as compared with male pharmacists (χ2= 5.383,
P= 0.020). Other factors that significantly associated with practice
status were age (χ2= 5.322, P= 0.025) and education level (χ2=
9.831, P= 0.020) (Table 2).
Factors Associated With Good KAP About COVID-19
A binary logistic regression analysis was performed to evaluate
the substantial determinants of good KAP about COVID-19
among CPs in Pakistan. Findings indicated that female partic-
ipants had 0.243 times lower odds (OR: 0.243, 95% CI: 0.135–
0.436, P =< 0.001) of good knowledge as compared with male
counterparts. Results revealed that age ≥ 26 years (OR: 2.046,
95% CI: 1.214–3.450. P = 0.007), PhD degree level (OR: 14.16,
95% CI: 0.875–22.95, P = 0.042), and good knowledge (OR:
2.045, 95% CI: 1.233–3.391, P = 0.006) were the significant
determinants of a good attitude. Similarly, a CP who had expe-
rience > 5 years (OR: 1.505, 95% CI: 0.944–2.40, P = 0.048), a
PhD degree (OR: 6.574, 95% CI: 0.362–11.942, P = 0.021), good
knowledge (OR: 2.448, 95% CI: 1.485–2.376, P =< 0.001), and a
good attitude (OR: 1.518, 95% CI: 0.970–2.376, P = 0.048) had
higher odds of good practice as compared with reference catego-
ries (Table 3). The Pearson correlation tests showed a linear sta-
tistically significant positive correlation amid KAP scores as
follows: knowledge-attitude (r = 0.274, P =< 0.001), attitude-
practice (r= 0.170, P= 0.001), and knowledge-practice (r= 0.341,
P=< 0.001) (Table 4).
Discussion
Pharmacists play a pivotal role in the provision of drug-related
information to patients, caregivers, and health care practitioners.20
The FIP emphasizes the active role of pharmacists in the commu-
nity and hospital setups in preventing the spread of COVID-19.10
Pharmacists are easily available and readily accessible to the gen-
eral population all the time. They are the first point of contact for
all those individuals who need medicine and information about
Figure 2. Practices among community pharmacists regarding COVID-19.
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χ2(P)(n [%]) (n [%]) (n [%]) (n [%]) (n [%]) (n [%])
Total 112 (28.5) 281 (71.5) 220 (56.0) 173 (44.0) 168 (42.7) 225 (57.3)
Gender 18.78 (< 0.001) 4.789 (0.033) 5.383 (0.020)
Male 39 (19.0) 166 (81.0) 104 (50.7) 101 (49.3) 99 (48.3) 106 (51.7)
Female 73 (38.8) 115 (61.2) 116 (61.7) 72 (38.3) 69 (36.7) 119 (63.3)
Age 0.775 (0.379) 10.171 (0.001) 0.049 (0.825)
≤ 25 years 39 (31.5) 85 (68.5) 84 (67.7) 40 (32.3) 52 (41.9) 72 (58.1)
≥ 26 years 73 (27.1) 196 (72.9) 136 (50.6) 133 (49.4) 116 (43.1) 153 (56.9)
Marital status 1.827 (0.172) 0.166 (0.684) 5.322 (0.025)
Married 27 (23.7) 87 (76.3) 62 (54.4) 52 (45.6) 59 (51.8) 55 (48.2)
Single 85 (30.5) 194 (69.5) 158 (56.6) 121 (43.4) 109 (39.1) 170 (60.9)
Pharmacy ownership 0.894 (0.674) 0.832 (0.660) 0.700 (0.705)
Owned 16 (23.9) 51 (76.1) 35 (52.2) 32 (47.8) 26 (38.8) 41 (61.2)
Partnership 12 (28.6) 30 (71.4) 22 (52.4) 20 (47.6) 17 (40.5) 25 (59.5)
Employed 84 (29.6) 200 (70.4) 163 (57.4) 121 (42.6) 125 (44.0) 159 (56.0)
Experience 0.013 (0.909) 0.259 (0.611) 2.136 (0.144)
≤ 5 years 76 (28.7) 189 (71.3) 146 (55.1) 119 (44.9) 120 (45.3) 145 (54.7)
> 5 Years 36 (28.1) 92 (71.9) 74 (57.8) 54 (42.2) 48 (37.5) 80 (62.5)
Education level 1.760 (0.624) 6.093 (0.047) 9.831 (0.020)
B-Pharm 3 (50.0) 3 (50.0) 5 (83.3) 1 (16.7) 3 (50.0) 3 (50.0)
Pharm-D 78 (28.8) 193 (71.2) 154 (56.8) 117 (43.2) 107 (39.5) 164 (60.5)
Master/MPhil 28 (26.2) 79 (73.8) 59 (55.1) 48 (44.9) 57 (53.3) 50 (46.7)
PhD 3 (33.3) 6 (66.7) 2 (22.2) 7 (77.8) 1 (11.1) 8 (88.9)
Need of education? 0.392 (0.531) 1.828 (0.176) 0.320 (0.572)
Yes 98 (29.1) 239 (70.9) 184 (54.6) 153 (45.4) 146 (43.3) 191 (56.7)
No 14 (25.0) 42 (75.0) 36 (64.3) 20 (35.7) 22 (39.3) 34 (60.7)
Level of concern? 11.603 (0.021) 12.886 (0.005) 4.576 (0.334)
Very high concern 68 (29.4) 163 (70.6) 113 (48.9) 118 (51.1) 97 (42.0) 134 (58.0)
High concern 29 (23.8) 93 (76.2) 80 (65.6) 42 (34.4) 48 (39.3) 74 (60.7)
Moderate concern 11 (31.4) 24 (68.6) 24 (68.6) 11 (31.4) 19 (54.3) 16 (45.7)
Low concern 3 (100.0) 0 (0.0) 1 (33.3) 2 (66.7) 2 (66.7) 1 (33.3)











medicines.21-23 To the best of our knowledge, not a single study
assessed KAPs among CPs toward COVID-19 in 2major provinces
of Pakistan.
In this study, it is revealed that the majority of the respondents
used social media (45.3%) followed by research articles (18.6%) as
their primary source to get information about COVID-19. These
results were comparable with the findings of Basheti et al.
(59.5%),3 Saqlain et al. (87.7%),24 and Giao et al. (91.1%).25
Conversely, Kara et al. reported that the participants generally used
television, newspapers, and the Internet as a principal source to get
information about COVID-19.20 Moreover, the current study
showed that research articles were also searched by CPs as a
source of information because valid and satisfactory informa-
tion can be obtained from standard research articles. The CPs
can be misguided by the false information that is available on
the Internet and circulates through social media. Therefore,
the CPs and other HCPs should carefully evaluate sources of
COVID-19 information and use only standard and authentic
content to seek information.20,26
A good knowledge, positive attitude, and practices among CPs
regarding basic precautionary measures (eg, wearing protective
clothing, goggles, face mask, and gloves) are important because
it decreases the chances of transmission. Moreover, the current
pandemic nature of the COVID-19 has made it mandatory for
CPs to increase their precautions and follow the recommended
Table 3. Regression analysis for factors associated with good knowledge, attitude, and practice regarding COVID-19
Variables
Knowledge Attitude Practice
OR (95% CI) P OR (95% CI) P OR (95% CI) P
Gender
Male 1.00 − 1.00 − 1.00 −
Female 0.243 (0.135-0.436) < 0.001 0.859 (0.507-1.455) 0.572 1.79 (1.038-3.086)
Age
≤ 25 years Reference − 1.00 − 1.00 −
≥ 26 years 1.783 (1.425-2.282) 0.281 2.046 (1.214-3.450) 0.007 1.395 (0.822-2.368) 0.217
Marital status
Married 1.00 − 1.00 − 1.00 −
Single 1.022 (0.562-1.857) 0.944 1.181 (0.708-1.969) 0.525 1.607 (0.955-2.704) 0.074
Pharmacy ownership
Owned 1.00 − 1.00 − 1.00 −
Partnership 0.785 (0.180-1.664) 0.991 1.039 (0.440-2.453) 0.931 0.902 (0.379-2.148) 0.816
Employed 0.866 (0.426-1.760) 0.690 1.006 (0.550-1.841) 0.984 0.694 (0.377-1.277) 0.240
Experience
≤ 5 years 1.00 − 1.00 − 1.00 −
> 5 years 1.107 (0.671-1.826) 0.690 1.007 (0.638-1.590) 0.976 1.505 (0.944-2.40) 0.048
Education?
B-Pharm 1.00 − 1.00 − 1.00 −
Pharm-D 2.307 (0.207-25.735) 0.390 4.268 (0.440-41.41) 0.211 1.928 (0.163-5.288) 0.133
Master/MPhil 2.707 (0.465-1.748) 0.281 4.663 (0.374-35.83) 0.265 2.618 (1.106-4.621) 0.193
PhD 3.541 (0.623-20.139) 0.497 14.16 (0.875-22.95) 0.042 6.574 (0.362-11.942) 0.021
Need of education?
Yes 1.00 − 1.00 − 1.00 −
No 1.933 (0.942-3.970) 0.073 0.626 (0.333-1.176) 0.145 1.107 (0.585-2.093) 0.754
Level of concern?
Very high concern 1.00 − 1.00 − 1.00 −
High concern 0.991 (0.496-1.793) 0.220 3.496 (0.308-3.800) 0.004 0.491
Moderate concern 0.878 (0.496-1.793) 0.278 3.443 (0.200-3.980) 0.044 0.528
Low concern 0.799 (0.013-1.071) 0.999 2.498 (0.198-3.193) 0.479 0.453
Very low concern 0.782 (0.019-1.028) 0.999 2.368 (0.143-3.872) 0.899 0.899
Knowledge − −
Poor − − 1.00 − 1.00 −
Good − − 2.045 (1.233-3.391) 0.006 2.448 (1.485-2.376) < 0.001
Attitude − − − −
Poor − − − − 1.00 −
Good − − − − 1.518 (0.970-2.376) 0.048
Table 4. Correlation between scores of knowledge, attitude, and practice
Variable Correlation Coefficient P-Value
Knowledge-Attitude 0.274* < 0.001
Attitude-Practice 0.170* 0.001
Knowledge-Practice 0.341* < 0.001
*Correlation significant at 0.05 level (2-tailed).
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hygienic protocols. Good knowledge and practice of CPs in com-
plying with precautionary measures not only create awareness
among patients, but also give an important message in society.3,20
The majority of respondents (71.5%) in this study had good
knowledge regarding COVID-19. Other findings revealed that
the knowledge of CPs was significantly different by the level of con-
cern and gender. The recent studies conducted in Turkey (90%)
among pharmacists,20 in Iran (56.5%) among nurses,26 in
Pakistan (93.2%),24 and in China (88.4%) among HCPs25 showed
different knowledgeable rates about COVID-19. The results of this
study provide confidence in terms of CP knowledge regarding
signs, transmission, and preventive measures of COVID-19.
Currently, there is no specific antiviral therapy or recommended
vaccine for COVID-19, so health practitioners, including CPs,
should take all the precautionary steps in the prevention and treat-
ment of this disease.3,8,24 Almost 30.80% of the respondents didn’t
know it is a zoonotic disease. Similar findings were reported by
Kara et al. (30%).20 However, it is reported that COVID-19 was
closely linked to a wet market in China, and other viral diseases,
such as SARS, MERS, Leptospirosis, Crimean-Congo hemorrhagic
fever, Dengue, and Ebola emerged from zoonotic origins.2,3,27-31
Furthermore, about 28.8% of respondents reported incorrectly that
antibiotics are the first-line treatment. At present, COVID-19
treatments include repurposing the available therapeutic drugs.32
Antibiotics are not the first-line effective drug in treating
COVID-19, and misuse of antibiotics can lead to antimicrobial
resistance.33
Regression analysis revealed that females had lower odds (OR:
0.243, P< 0.001) of good knowledge as compared with their male
counterparts (OR: 1.00). However, Zhong et al.5 showed that males
(vs female, β: -0.284, P< 0.001) were significantly associated with
lower knowledge scores. Significantly higher knowledge scores
among males than females may be related to a higher level of edu-
cation among males in Pakistan. The finding suggests that inter-
vention via health education can be more efficient if it targets
specific demographic groups, such as the COVID-19 knowledge
that may be markedly increased if the health education programs
are certainly designed for females.5,24 The majority of the CPs
(92.4%) perceived that they can play an important role in this pan-
demic. Similar findings were reported by Basheti et al. in Jordan
(70%).3 Nearly 36.6% of the participants perceived that govern-
ment health care institutes in Pakistan can control COVID-19,
whereas 28.8% disagreed. A recent study conducted in China
reported that the majority of the respondents (97.1%) were confi-
dent and agreed that their government can win the fight against
COVID-19.5
The lack of confidence among the participants in the current
study may be due to the lack of basic health facilities and recom-
mended policies, absence of proper medical equipment, financial
crisis, and weak economic condition of Pakistan to cope with such
outbreaks.15 Additionally, about 36.10% of the respondents dis-
agreed that the Pakistani populations have sufficient information.
This may be due to the perception that the Pakistani population
has limited access to the Internet, limited health information
resources, and mostly live in rural areas.
This study demonstrated that only 44% of the participants had a
positive attitude toward COVID-19. The attitude status of CPs
about COVID-19 needs further improvement. These results can
be used by the general public, policy-makers, and health workers
to analyze the targeted population for the prevention of COVID-
19. Regression analysis revealed that CPs of ages ≥ 26 years had
higher odds (OR: 2.406, P=< 0.001) of demonstrating a good
attitude, which is in line with a Turkish study that also reported
that age was a factor that influenced participants’ attitudes toward
COVID-19 infection.20 On the contrary, a study conducted in
China did not reveal any association to age, gender, and experience
with attitude level.25 This variation could be possibly explained by
the geographical difference between these countries. Findings also
showed that pharmacists with a higher-level degree (PhD) had bet-
ter (OR: 14.16, P= 0.048) attitudes as compared with those with
other educational levels. These findings are also supported by
Naser et al.34 and Zhong et al.5 A higher educational degree
appreciably increases knowledge and, ultimately, a positive atti-
tude. Targeted educational programs are needed to raise aware-
ness about COVID-19. Such programs need to be tailored to
young individuals and particularly to those with lower educa-
tion levels.34,35 A participant who had a higher level of concern
demonstrated a good attitude as compared with less concerned
pharmacists. The good knowledge among participants was
found to be a potential predictor of a positive attitude (OR:
2.045, P = 0.006), as knowledge is positively correlated with atti-
tude (r = 0.274, P =< 0.001). Our finding was supported by the
studies conducted in China,5 Iran,26 and Thailand.36 Therefore,
continuous educational programs and periodic training may be
an effective intervention to improve the knowledge, level of con-
cern, and, ultimately, attitude of the CP about COVID-19.
More than half (57.3%) of the respondents showed good prac-
tices toward COVID-19. The overall highest practice observed
among participants was regarding throwing the used tissue in
the trash (91.9%) followed by wearing a face mask (91.6%) and
washing hands (90.6%). A recently conducted study showed that
only 8.9% of the pharmacists used face masks and 84.8% washed
their hands at the workplace.20 The spread of COVID-19 can be
prevented if health care workers wash their hands with soap and
water at specific times and maintain an excellent hygiene condi-
tion. However, the least practice observed among participants
was wearing protective gowns (57.5%). This result is of special con-
cern because good knowledge with poor practice not only increases
the transmission of infection but also increases the morbidity and
mortality rates in the community.37 It was noted that personal pro-
tective equipment decreases the transmission of microbes in the
hospital setup and also protects people from infections in the com-
munity. Therefore, it is mandatory for various CPs and other HCPs
to follow the practice guidelines recommended by the National
Institute of Health, Islamabad, Pakistan, Centers for Disease
Control and Prevention, and the WHO regarding COVID-19. It
further suggests that CPs and other health care workers boost their
knowledge and attitude that will ultimately translate into good
practices.
Findings showed that CPs with good knowledge (OR: 2.44,
P< 0.01) and a positive attitude (OR: 1.15, P= 0.048) demon-
strated good practices in following precautionary measures. The
studies conducted by Kara et al.,20 Saqlain et al.,24 and Naser
et al.34 indicated that pharmacists with good knowledge had a good
attitude and showed good practices. Therefore, adequate knowl-
edge is important and could be improved via an extensive educa-
tional program for better understanding and improved practices.38
Strengths of the Study
The study respondents were CPs, who are educated and
professionals who answered with responsibility. This study was
a computer-generated survey and is free of errors as compared
to hand-filled proforma. Moreover, it describes CP KAPs toward
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COVID-19 in detail, which suggests that the health ministry
focuses on it. The WHO published materials that were used in
the development of the questionnaire, and a 2-step data validation
technique was used, hence all these factors increase the reliability of
the questionnaire.
Limitations of the Study
This study was carried out in 2 provinces, and the remaining prov-
inces of Pakistan were not included, hence the study can’t be gen-
eralized for the whole country. This study is the unstandardized
and inadequate assessment of attitudes and practices toward
COVID-19, which should be established through focus group dis-
cussion and comprehensive interviews and constructed as multi-
dimensional measures.
Conclusion
The CPs had good knowledge but had a poor attitude and poor
practices toward COVID-19. The majority of the CPs perceived
that they can play an important role in this pandemic. This study
also highlighted the disparity in some aspects of KAP that must be
addressed in future educational, awareness, and counseling pro-
grams. It is important for pharmacists to have standard authentic
information about COVID-19 and to further convey this knowl-
edge and belief to the community. Future studies are required to
evaluate KAPs of other HCPs and other segments of society.
This study recommends that the health ministry and other associ-
ated authorities promote awareness about COVID-19 and its
related symptoms with a comprehensive training program. These
programs should be consisting of better-structured targeting not
only for medical doctors, but also for pharmacists, nurses, and
other paramedical staff to build equilibrium in clinical knowledge
about COVID-19.
Supplementary material. To view supplementary material for this article,
please visit https://doi.org/10.1017/dmp.2021.54
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